NewsBenzingaRBC Capital mantiene il rating Outperform su Stryker, abbassa il prezzo obiettivo a 375 dollari RBC Capital mantiene il rating Outperform su Stryker, abbassa il prezzo obiettivo a 375 dollari Benzinga 2026.10.30 17:18 (GMT+0) Open on Benzinga Other news DA Davidson Maintains Buy on UFP Industries, Lowers Price Target to $96 Telsey Advisory Group Maintains Outperform on Coursera, Lowers Price Target to $7 Intel Agreed to Buy Israeli Startup Classiq Technologies. How Investors Should View the Deal. DA Davidson Maintains Neutral on Intel, Lowers Price Target to $70 Elon Musk Sees Midterm Elections as A 'Crusade,' Is All In on Republicans, Biographer Says U.S. Approves $2.1B Sale Of 500 Patriot Missiles To Ukraine
